SCHEMBL19008849

SCHEMBL19008849

C/N=N/c1cc(C)ccc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.44
MAPT P10636 6/20 0.44
RAB9A P51151 5/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
MAPK1 P28482 3/20 0.44
PKM P14618 1/20 0.44
ATM Q13315 1/20 0.44
TDP1 Q9NUW8 5/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
KDM4E B2RXH2 2/20 0.41
AGTR1 P30556 1/20 0.41
HTT P42858 1/20 0.41
ALDH1A1 P00352 2/20 0.41
GAA P10253 1/20 0.39
DHODH Q02127 1/20 0.39
RAPGEF4 Q8WZA2 1/20 0.38
FTO Q9C0B1 1/20 0.37
TP53 P04637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11695540 0.87 NPC1 (0.54) NPC1MAPTRAB9AL3MBTL1MAPK1
SCHEMBL11695545 0.87 NPC1 (0.54) NPC1MAPTRAB9AL3MBTL1MAPK1
SCHEMBL22755750 0.81 NPC1 (0.59) NPC1MAPTRAB9AL3MBTL1MAPK1
SCHEMBL3950942 0.80 TDP1 (0.44) NPC1MAPTRAB9AL3MBTL1MAPK1
SCHEMBL11020065 0.79 TDP1 (0.44) NPC1MAPTRAB9AL3MBTL1MAPK1
SCHEMBL11022109 0.79 TDP1 (0.44) NPC1MAPTRAB9AL3MBTL1MAPK1
SCHEMBL11139922 0.74 KMT2A (0.52) NPC1MAPTRAB9AL3MBTL1MAPK1
SCHEMBL11139916 0.74 KMT2A (0.52) NPC1MAPTRAB9AL3MBTL1MAPK1
SCHEMBL1485807 0.73 TDP1 (0.42) NPC1MAPTRAB9AL3MBTL1MAPK1
SCHEMBL2662650 0.73 GAA (0.45) NPC1MAPTRAB9AL3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021214781-A1 COSMETIC COMPOSITIONS COMPRISING DRAGLINE SPIDER SILK SEEVIX MATERIAL SCIENCES LTD. (IL) 2021-10-28 WO disclosed
US-9988333-B2 Process for making 2,5-dihalogenated phenol BASF SE (DE) 2018-06-05 US disclosed
US-20170174603-A1 Process for Making 2,5-Dihalogenated Phenol BASF SE (DE) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174603-A1 Process for Making 2,5-Dihalogenated Phenol TYR, CA4, CA6 NPC1 3826/4885MAPT 2265/4885RAB9A 1513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.